Workflow
莱美药业:2025一季报净利润-0.14亿 同比下降180%

Group 1 - The core viewpoint of the articles indicates a significant decline in certain financial metrics for the year 2024 compared to 2023, with notable percentage changes in various categories [1][2] - The financial data shows a drastic decrease in the metric labeled as "■■■■■■■■■■" with a change of -202.33% from 2023 to 2024, indicating a negative trend [1] - Another metric, "■■■■■■■■■," experienced a decrease of -10.66% from 2023 to 2024, suggesting a downward trajectory in performance [1] Group 2 - The total financial figure reported is 43175.65 million, with a percentage of 40.88% noted, indicating a substantial portion of the overall financial landscape [2] - The metric "■■■■■■■■■■600252" shows a value of 24742.61 million with a percentage of 23.43%, highlighting its significance in the overall financial context [2] - A specific entry labeled "■■■■(■■)■■■■■■■■■■■■■■■■■■(2144.78 ■■■■)" has a percentage of 2.03, which may reflect a minor but relevant aspect of the financial data [2]